glp 1 cancer GLP-1s appear to cut risk. Researchers are asking why and how : NPR Frontiers | GLP-1 receptor agonist
Description
It slows digestion, stabilizes blood sugar, and helps you feel fuller longer
Li LC, Liang LM, Ji HY, Zhang C, Wang M, Liu HS
Are there specific cancer types I should be more concerned about with these medications
Studies in patients with diabetes have shown that at the 28-week mark, people taking 1 mg of semaglutide lose approximately 7% of their weight
Differential Risk of Cancer Associated with Glucagon-like Peptide-1 Receptor Agonists: Analysis of Real-world Databases
A recent study suggests a potential link between Ozempic (semaglutide) use and non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition that can cause sudden, permanent vision loss
